Kevin M. Connolly
CEO and ChairmanMr. Connolly is a career entrepreneur who has founded and operated five medical device companies, all of which manufactured proprietary devices. He is also Founder/CEO of Personal Medical Corp., a manufacturer of devices for female pelvic health. Previously, Mr. Connolly was Founder/CEO of SRS Medical, a manufacturer of urodynamics systems and other bladder-related technologies now owned by Schooner Capital of Boston MA. Prior to SRS Medical, Mr. Connolly was Founder/CEO of Fasstech, Inc., a manufacturer of medical instruments that was merged into SRS Medical. Prior to Fasstech, Mr. Connolly was Founder/CEO of Davicon, Inc., a medical instrument manufacturer that he sold to a group of private investors.
B.G. Susan Robinson
Chief Operating OfficerSusan Robinson is a full-time consultant to the company who has over 20 years of experience in the biotech industry, most recently as CEO and a Director of Targeted Genetics Corporation, a publicly traded biotech company. She completed a sale of this company in early 2011. Prior to this role Ms. Robinson held business development roles at Targeted Genetics and Genzyme Molecular Oncology. She was integral to strategic planning efforts for these companies and completed numerous academic and corporate technology licenses, sponsored research agreements, pharma/ biotech collaboration agreements, asset sales and company acquisitions.
Terence Moore
EVP Marketing / SalesMr. Moore has 30 years’ experience in the medical device industry, with more than half devoted to the urology and gynecology sectors. He has specialized in driving adoption of new technologies and therapies in varied sales and marketing capacities for start-up, early-stage and established companies, including for Endocare, HealthTronics, Conceptus, American Medical Systems (AMS) and Influence Medical, developers of the inFlow.
John W. Sullivan
CFO (Acting)Mr. Sullivan is consulting as CFO while serving as the full-time CFO for a Seattle pharmaceutical business. Mr. Sullivan has 20 years’ experience in healthcare finance on both the operational side as well as the transaction side in capital raising and M&A. He was the Director of Research at Healthios, a Chicago healthcare investment bank. Prior to that, Mr. Sullivan was the CFO at Pharos Innovations, a remote patient monitoring company and was an equity research analyst at Barclays. Mr. Sullivan has an MBA and is a CPA.
T. Loran Van Noy
Senior DirectorMr. Van Noy is a senior medical products executive with decades of experience in both large multi-national firms and startups, including being CEO of Diagnostic Ultrasound (now Verathon), manufacturer of the BladderScan® and Former President of KCI Therapeutics, a major business unit of KCI, a $1B public company that provides world-wide rentals and sales of equipment to the acute / extended care clinical markets.
Michael J. Kennelly
M.D.Michael J. Kennelly, M.D., is fellowship trained and board certified urologist with subspecialty certification in female pelvic medicine and reconstructive surgery. Academically, he is a Professor in the Department of Urology at Carolinas Medical Center and at the University of North Carolina Medical School – Charlotte Campus and actively involved in the training of fellows and residents. Administratively, he is Medical Director of the Charlotte Continence Center at Carolinas Medical Center, Director of Urology at Carolinas Rehabilitation Hospital, and Co-Director of the Women’s Center for Pelvic Health. Dr. Kennelly has authored or coauthored a number of journal articles, book chapters, and educational videos in the areas of urinary incontinence and neurourology and has lectured extensively on these topics. A Fellow of the American College of Surgeons, he is also a member of more than 15 professional organizations and holds several leadership positions.
Richard Schmidt
M.D.Richard Schmidt, M.D., is considered one of the world’s leading experts in neuro-urology and is the author of 118 peer-reviewed articles on voiding function and pathology. He is the co-inventor of the Medtronic InterStim and conducted much of the developmental work on methods for using Botox for urologic dysfunctions. Dr. Schmidt served on the Editorial Board of Neurology and Urodynamics, the journal of the International Continence Society, and Chaired the 1999 International Continence Society Meeting. He is Former Professor of the Department of Urology at the University of San Francisco School of Medicine and of the Division of Urology at the Colorado School of Medicine and has trained 25 research fellows. Throughout his 40-year career Dr. Schmidt has maintained an active urology practice.
Roger R. Dmochowski
M.D.Roger R. Dmochowski, M.D., is Professor at the Department of Urology at Vanderbilt University in Nashville, as well as the Director of the Section of Female Pelvic Medicine and program director of the Fellowship in Pelvic Medicine at Vanderbilt; Clinical Assistant Professor in Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Maryland; Vice Chair, Section of Surgical Sciences Vanderbilt University Medical Center, Associate Director of Quality and Safety, Vanderbilt Health System; Executive Director of Risk Prevention for Vanderbilt Health System; Executive Medical Director for Patient Safety and Quality (Surgery), Associate Chief of Staff, and Medical Director of Risk Management at Vanderbilt University Hospital. Dr. Dmochowski is board certified in urology and female pelvic medicine and reconstruction and is subspecialty fellowship trained in female urology, neurourology, urodynamics and reconstructive urology. He has published more than 370 articles and 110 book chapters, and 460 abstracts, has given over 280 presentations at various national and international meetings and is currently the Editor in Chief of Neurourology and Urodynamics.
Steven Siegel
M.D.Steven Siegel, M.D., is an FPMRS specialist and has served as the Director of the Minnesota Urology Centers for Female Urology and Continence Care. He established this center of excellence after moving to Minnesota in 1993. Previously, he was the Head of the Section of Female Urology and Urodynamics at the Cleveland Clinic in Cleveland, Ohio. He graduated from the University of Michigan Medical School, and completed his urology residency at the Cleveland Clinic in 1986. Dr. Siegel is internationally recognized for his work related to urinary incontinence and voiding dysfunction. Dr. Siegel has trained over 30 fellows, some of whom have been recognized as “Top Doctors” and “Top Doctors for Women” in their communities of practice. In 2018, he was the AUGS recipient of the National Association for Continence “Continence Care Champion” award. He received the Christina Manthos Award for demonstrating extraordinary mentoring skills in supporting the careers of female urologists from the Society of Women in Urology in 2011. He was also honored with the David C. Utz Award for Urological Advancement and Innovation from the Minnesota Urological Society in 2002. He is a recent Past President of the North Central Section of the American Urological Association (2010), board member and Chairman of the Practice Standards Committee of the SUFU. He previously served as a founding member and President of the International Society for Pelvic Neuromodulation.
Matthew Rutman
M.D.Matthew Rutman, M.D., is an Associate Professor of Urology at CUMC and is the Director of Voiding Dysfunction, Incontinence and Female Urology at Columbia University Medical Center. He is also Director of the Female Urology and Voiding Dysfunction Fellowship. Dr. Rutman is board-certified in Urology and Female Pelvic Medicine and Reconstructive Surgery (FPMRS) and completed a fellowship in female urology, voiding dysfunction, neurourology and urodynamics under world renowned Shlomo Raz, M.D at the UCLA Medical Center. His practice is limited to male and female voiding dysfunctions including urinary retention. Dr. Rutman has authored over 40 book chapters and publications in leading journals and urology textbooks. His clinical and research interests are in male and female incontinence, vaginal prolapse, voiding dysfunction, urodynamics and surgical outcomes.
